Sahajanand Medical Technologies Adopts Fair Disclosure Code
Sahajanand Medical Technologies Ltd has adopted a "Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information" in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The code, effective November 12, 2025, outlines procedures for timely and uniform dissemination of UPSI to prevent misuse and ensure transparency. It designates the Company Secretary & Compliance Officer as the Chief Investor Relations Officer (CIRO) responsible for managing disclosures. The company commits to prompt public disclosure of UPSI via stock exchanges and its website, uniform dissemination to all stakeholders, and appropriate responses to market rumors. Interactions with analysts and investors will ensure no selective disclosure of UPSI.
Key Highlights
- Company adopted SEBI-compliant fair disclosure code for UPSI.
- Code ensures timely and uniform dissemination of price-sensitive information.
- CIRO appointed to manage disclosures and prevent selective disclosure.
- Company commits to transparency with stakeholders.
- Procedures for handling analyst interactions and market rumors outlined.
Price Impact
More from SMT